 | • レポートコード：TMR2112A046 • 出版社/出版日：Transparency Market Research / 2021年11月25日 • レポート形態：英文、PDF、197ページ • 納品方法：Eメール • 産業分類：バイオ |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprisewide | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートは、生物分析サービスの世界市場を調査対象とし、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、サービス別（免疫化学サービス、定量的イムノアッセイ、細胞ベース中和アッセイ、LCMSメソッド開発、発見段階生物分析）分析、種類別分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の構成でまとめております。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・生物分析サービスの世界市場規模：サービス別（免疫化学サービス、定量的イムノアッセイ、細胞ベース中和アッセイ、LCMSメソッド開発、発見段階生物分析） ・生物分析サービスの世界市場規模：種類別 ・生物分析サービスの世界市場規模：エンドユーザー別 ・生物分析サービスの世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Bioanalytical Services Market – Scope of Report
TMR’s report on the global bioanalytical services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2017 to 2031. The report provides the overall market revenue of the global bioanalytical services market for the period 2017–2031, considering 2017 to 2019 as historical years, 2020 as the base year, and 2021 to 2031 as the forecast period. The report also provides the compound annual growth rate (CAGR) for the global bioanalytical services market for the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, articles, journals, and relevant documents to understand the global bioanalytical services market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a top-down approach to study various phenomena in the global bioanalytical services market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global bioanalytical services market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global bioanalytical services market. The next section of the global bioanalytical services report highlights the USPs, which include key mergers & acquisitions, technological advancements, major research institutes involved, pricing analysis, and key developments in the global bioanalytical services market.
The report delves into the competition landscape of the global bioanalytical services market. Key players operating in the global bioanalytical services market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global bioanalytical services market profiled in this report.
Key Questions Answered in Bioanalytical Services Market Report
What are the major drivers, restraints, and opportunities in the market?
What will be the revenue share projections of key segments of the global bioanalytical services market during the forecast period?
Which segment is likely to lead the global bioanalytical services market in terms of revenue by 2031?
How mergers & acquisitions among players are widening the scope of the global bioanalytical services market?
Which are the leading companies in the global bioanalytical services market?
Bioanalytical Services Market – Research Objectives and Research Approach
The comprehensive report on the global bioanalytical services market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of research in the global bioanalytical services market. It is followed by market introduction, market dynamics, and an overview of the global bioanalytical services market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the global bioanalytical services market. Furthermore, to understand the Y-o-Y trends of the bioanalytical services market, a Y-o-Y analysis with elaborate insights on the same has been provided. The next section of the global bioanalytical services report highlights the USPs, which include technology snapshot, process overview, prominent software tools, key industry developments, regulatory scenario, and reimbursement scenario of the global bioanalytical services market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global bioanalytical services market in terms of services, type, application, end-user, and region. Key segments under each criteria have been studied at length, and the market share for each of them at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the bioanalytical services market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bioanalytical Services Market
4. Market Overview
4.1. Introduction
4.1.1. Services Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bioanalytical Services Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.3. Technological Advancements
6. Global Bioanalytical Services Market Analysis and Forecast, by Service
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Services, 2017–2031
6.3.1. Immunochemistry Service
6.3.2. Quantitative Immunoassays
6.3.3. Cell-Based Neutralization Assays
6.3.4. LCMS Method Development
6.3.5. Discovery Phase Bioanalysis
6.3.6. LCMS Sample Bioanalysis
6.3.7. GCP Bioanalysis Service
6.3.8. Biomarker Assays
6.3.9. Protein Analysis
6.3.10. Others
6.4. Market Attractiveness By Service
7. Global Bioanalytical Services Market Analysis and Forecast, by Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Type, 2017–2031
7.3.1. Small Molecule Bioanalysis
7.3.2. Large Molecule Bioanalysis
7.3.3. Others
7.4. Market Attractiveness Analysis, by Type
8. Global Bioanalytical Services Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Pharma & Biotechnology Companies
8.3.2. Contract Research Organizations
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Bioanalytical Services Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Bioanalytical Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Service, 2017–2031
10.2.1. Immunochemistry Service
10.2.2. Quantitative Immunoassays
10.2.3. Cell-Based Neutralization Assays
10.2.4. LCMS Method Development
10.2.5. Discovery Phase Bioanalysis
10.2.6. LCMS Sample Bioanalysis
10.2.7. GCP Bioanalysis Service
10.2.8. Biomarker Assays
10.2.9. Protein Analysis
10.2.10. Others
10.3. Market Value Forecast, by Type, 2017–2031
10.3.1. Small Molecule Bioanalysis
10.3.2. Large Molecule Bioanalysis
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Pharma & Biotechnology Companies
10.4.2. Contract Research Organizations
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Service
10.6.2. By Type
10.6.3. By End-user
10.6.4. By Country
11. Europe Bioanalytical Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Service, 2017–2031
11.2.1. Immunochemistry Service
11.2.2. Quantitative Immunoassays
11.2.3. Cell-Based Neutralization Assays
11.2.4. LCMS Method Development
11.2.5. Discovery Phase Bioanalysis
11.2.6. LCMS Sample Bioanalysis
11.2.7. GCP Bioanalysis Service
11.2.8. Biomarker Assays
11.2.9. Protein Analysis
11.2.10. Others
11.3. Market Value Forecast, by Type, 2017–2031
11.3.1. Small Molecule Bioanalysis
11.3.2. Large Molecule Bioanalysis
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Pharma & Biotechnology Companies
11.4.2. Contract Research Organizations
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Service
11.6.2. By Type
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Bioanalytical Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Service, 2017–2031
12.2.1. Immunochemistry Service
12.2.2. Quantitative Immunoassays
12.2.3. Cell-Based Neutralization Assays
12.2.4. LCMS Method Development
12.2.5. Discovery Phase Bioanalysis
12.2.6. LCMS Sample Bioanalysis
12.2.7. GCP Bioanalysis Service
12.2.8. Biomarker Assays
12.2.9. Protein Analysis
12.2.10. Others
12.3. Market Value Forecast, by Type, 2017–2031
12.3.1. Small Molecule Bioanalysis
12.3.2. Large Molecule Bioanalysis
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Pharma & Biotechnology Companies
12.4.2. Contract Research Organizations
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Service
12.6.2. By Type
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Bioanalytical Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Service, 2017–2031
13.2.1. Immunochemistry Service
13.2.2. Quantitative Immunoassays
13.2.3. Cell-Based Neutralization Assays
13.2.4. LCMS Method Development
13.2.5. Discovery Phase Bioanalysis
13.2.6. LCMS Sample Bioanalysis
13.2.7. GCP Bioanalysis Service
13.2.8. Biomarker Assays
13.2.9. Protein Analysis
13.2.10. Others
13.3. Market Value Forecast, by Type, 2017–2031
13.3.1. Small Molecule Bioanalysis
13.3.2. Large Molecule Bioanalysis
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Pharma & Biotechnology Companies
13.4.2. Contract Research Organizations
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Service
13.6.2. By Type
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Bioanalytical Services Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Service, 2017–2031
14.2.1. Immunochemistry Service
14.2.2. Quantitative Immunoassays
14.2.3. Cell-Based Neutralization Assays
14.2.4. LCMS Method Development
14.2.5. Discovery Phase Bioanalysis
14.2.6. LCMS Sample Bioanalysis
14.2.7. GCP Bioanalysis Service
14.2.8. Biomarker Assays
14.2.9. Protein Analysis
14.2.10. Others
14.3. Market Value Forecast, by Type, 2017–2031
14.3.1. Small Molecule Bioanalysis
14.3.2. Large Molecule Bioanalysis
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Pharma & Biotechnology Companies
14.4.2. Contract Research Organizations
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Service
14.6.2. By Type
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix
15.2. Market Share Analysis, by Company, 2020
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. PPD, Inc.
15.4.1.1. Company Description
15.4.1.2. Business Overview
15.4.1.3. Financial Overview
15.4.1.4. SWOT Analysis
15.4.2. ICON plc
15.4.2.1. Company Description
15.4.2.2. Business Overview
15.4.2.3. Financial Overview
15.4.2.4. SWOT Analysis
15.4.3. Laboratory Corporation of America
15.4.3.1. Company Description
15.4.3.2. Business Overview
15.4.3.3. Financial Overview
15.4.3.4. SWOT Analysis
15.4.4. Charles River Laboratories International, Inc.
15.4.4.1. Company Description
15.4.4.2. Business Overview
15.4.4.3. Financial Overview
15.4.4.4. SWOT Analysis
15.4.5. Syneos Health
15.4.5.1. Company Description
15.4.5.2. Business Overview
15.4.5.3. Financial Overview
15.4.5.4. SWOT Analysis
15.4.6. SGS SA
15.4.6.1. Company Description
15.4.6.2. Business Overview
15.4.6.3. SWOT Analysis
15.4.7. Toxikon, Inc.
15.4.7.1. Company Description
15.4.7.2. Business Overview
15.4.7.3. SWOT Analysis
15.4.8. Intertek Group
15.4.8.1. Company Description
15.4.8.2. Business Overview
15.4.8.3. Financial Overview
15.4.8.4. SWOT Analysis
15.4.9. Pace Analytical Services
15.4.9.1. Company Description
15.4.9.2. Business Overview
15.4.9.3. SWOT Analysis
15.4.10. Medpace
15.4.10.1. Company Description
15.4.10.2. Business Overview
15.4.10.3. Financial Overview
15.4.10.4. SWOT Analysis
15.4.11. PRA HEALTH SCIENCES
15.4.11.1. Company Description
15.4.11.2. Business Overview
15.4.11.3. Financial Overview
15.4.11.4. SWOT Analysis
15.4.12. WuXi AppTec
15.4.12.1. Company Description
15.4.12.2. Business Overview
15.4.12.3. Financial Overview
15.4.12.4. SWOT Analysis
15.4.13. IQVIA
15.4.13.1. Company Description
15.4.13.2. Business Overview
15.4.13.3. Financial Overview
15.4.13.4. SWOT Analysis
15.4.14. Eurofins Scientific
15.4.14.1. Company Description
15.4.14.2. Business Overview
15.4.14.3. Financial Overview
15.4.14.4. SWOT Analysis
Table 01: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 02: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 03: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 07: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 08: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Bioanalytical Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 11: Europe Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 12: Europe Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Bioanalytical Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 15: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 16: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 19: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 20: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 23: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 24: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031